Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT (Citrate PK)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bangkok, Thailand, 10330
- Chulalongkorn University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Critically ill ALF or ACLF adult patients with AKI
- aged ≥ 18 y old
- Currently receiving CRRT.
Exclusion Criteria:
- severe acidosis (pH < 7.1) or severe alkalosis (pH > 7.55)
- blood transfusion within 24 h prior to the study
- use of citrate-containing medications
- severe hypocalcemia (serum ionized calcium < 0.8 mmol/L)
- use of heparin as anticoagulation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Acute Liver Failure
Acute liver failure critically ill patients receiving CRRT
|
|
|
EXPERIMENTAL: Acute on top Chronic Liver Failure
Acute on top chronic liver failure critically ill patients receiving CRRT
|
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Citrate clearance
Time Frame: 4 hours
|
Citrate clearance by body
|
4 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Citrate accumulation
Time Frame: 4 hours
|
Number of total calcium to ionized calcium ratio > 2.5 with acidosis with hypocalcemia
|
4 hours
|
|
Tmax
Time Frame: 2 hours
|
Time to maximum concentration of citrate at 2 hours
|
2 hours
|
|
Area under the time curve
Time Frame: 4 hours
|
Area under the plasma concentration-time curve of citrate
|
4 hours
|
|
Change of systemic ionized calcium
Time Frame: 4 hours
|
Change in systemic ionized calcium in arterial blood gas during study
|
4 hours
|
|
Change of ionized magnesium
Time Frame: 4 hours
|
Change in systemic ionized magnesium in arterial blood gas during study
|
4 hours
|
|
Change of bicarbonate
Time Frame: 4 hours
|
Change of bicarbonate in arterial blood gas during study
|
4 hours
|
|
Ratio of total calcium to systemic ionized calcium
Time Frame: 4 hours
|
Number of patients with total calcium to systemic ionized calcium > 2.5 with or without metabolic acidosis
|
4 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB.694/63
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.